US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MariMed Inc.

0.0801

-0.0077-8.72%

Volume:1.16M

Turnover:95.09K

Market Cap:31.70M

PE:-1.61

High:0.0879

Open:0.0861

Low:0.0760

Close:0.0878

52wk High:0.2300

52wk Low:0.0670

Shares:395.60M

Float Shares:342.52M

Volume Ratio:2.82

T/O Rate:0.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0498

EPS(LYR):-0.0707

ROE:-22.81%

ROA:0.32%

PB:0.56

PE(LYR):-1.13

Loading ...

Overview Company News Filings

Marimed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results

Marimed Launches Hemp-Derived THC Vibations Beverages in Rhode Island

Noble Financial Remains a Buy on MariMed (MRMD)

Press Release: MariMed Reports Third Quarter 2025 Earnings

MariMed Q3 revenue misses analyst expectations

Marimed Inc. reports third quarter revenue of $40.8 million and net loss of $2.9 million

BRIEF-MariMed Q3 Adjusted EBITDA USD 5.1 Million

MariMed Q3 Gross Margin 40%

THOMSON REUTERS

MariMed Q3 Adjusted Gross Margin 41%

THOMSON REUTERS

BRIEF-Marimed Announces Exit From Missouri Market

MariMed Inc - Announces Exit From Missouri Market

THOMSON REUTERS

Marimed to expand distribution to New York

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MRMD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MRMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRMD\",,,,,undefined,":{"symbol":"MRMD","market":"US","secType":"STK","nameCN":"MariMed Inc.","latestPrice":0.08014,"timestamp":1771621200000,"preClose":0.0878,"halted":0,"volume":1160855,"delay":15,"changeRate":-0.08724373576309795,"floatShares":342520282,"shares":395599371,"eps":-0.04977,"marketStatus":"Market Closed","change":-0.00766,"latestTime":"02-20 16:00:00 EST Delay","open":0.0861,"high":0.0879,"low":0.076,"amount":95090.02023,"amplitude":0.135535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.04977,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQX","adjPreClose":0.0878,"volumeRatio":2.8179498398416065},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRMD\",,,,,undefined,":{"symbol":"MRMD","floatShares":342520282,"roa":"0.32%","roe":"-22.81%","lyrEps":-0.070716,"volumeRatio":2.8179498398416065,"shares":395599371,"dividePrice":0,"high":0.0879,"amplitude":0.135535,"preClose":0.0878,"low":0.076,"week52Low":0.067,"pbRate":"0.56","psRate":"0.20","week52High":0.23,"institutionHeld":0,"latestPrice":0.08014,"eps":-0.04977,"divideRate":0,"volume":1160855,"delay":15,"ttmEps":-0.04977,"open":0.0861,"prevYearClose":0.09396,"prevWeekClose":0.08,"prevMonthClose":0.0868,"prevQuarterClose":0.094,"fiveDayClose":0.0877,"twentyDayClose":0.0941,"sixtyDayClose":0.0846,"earningDate":1773158400000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRMD\",params:#limit:5,,,undefined,":[{"date":"2026-03-11","symbol":"MRMD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773259200000,"name":null,"time":"Post Market","dateTimestamp":1773201600000,"actualEps":null},{"date":"2025-11-05","symbol":"MRMD","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1762333200000,"name":null,"time":"","dateTimestamp":1762318800000,"actualEps":null},{"date":"2025-08-06","symbol":"MRMD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754510400000,"name":null,"time":"Post Market","dateTimestamp":1754452800000,"actualEps":null},{"date":"2025-05-07","symbol":"MRMD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1746648000000,"name":null,"time":"Post Market","dateTimestamp":1746590400000,"actualEps":null},{"date":"2025-03-05","symbol":"MRMD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1741208400000,"name":null,"time":"Post Market","dateTimestamp":1741150800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1762578000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRMD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610932247","title":"Marimed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2610932247","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610932247?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813035,"startTime":"0","endTime":"0","summary":"MariMed Inc. will report its fourth quarter and full year 2025 financial results on March 11, 2026, after the markets close. Management will host a conference call to discuss the financial results on March 12, 2026, at 8:00 a.m. EDT. The webcast can be accessed via MariMed Q425 Earnings Webcast, and a playback will also be available on MariMed's Investor Relations website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marimed Inc. published the original content used to generate this news brief via GlobeNewswire  on February 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL8XB61v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","MRMD","BK4585","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","IE00BKPKM429.USD","LU2210150020.SGD","BK4112","BK4007","BK4588","IE00BGHQF748.EUR","NDAQ","SG9999014005.SGD","IE00B64PRP62.GBP","LU2095319765.USD","LU0314104364.USD","SG9999014013.SGD"],"gpt_icon":0},{"id":"2605496310","title":"Marimed Launches Hemp-Derived THC Vibations Beverages in Rhode Island","url":"https://stock-news.laohu8.com/highlight/detail?id=2605496310","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605496310?lang=en_us&edition=fundamental","pubTime":"2026-01-22 20:30","pubTimestamp":1769085054,"startTime":"0","endTime":"0","summary":"MariMed Inc., a leading cannabis consumer packaged goods company, has expanded its presence in the hemp-derived THC market by launching a new version of its Vibations hydrating drink mix in Rhode Island. This move allows MariMed to enter the rapidly growing hemp THC beverage category through established retail channels, without the need for additional cultivation or retail infrastructure investment. The company is partnering with Craft Collective Homegrown for distribution and Modern Infusions for sales execution and local marketing. Plans are also underway to extend Vibations distribution into additional markets in the first half of 2026, depending on the performance of the Rhode Island launch and regulatory developments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as finan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL5jnQhX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","LU2210150020.SGD","IE00BGHQF748.EUR","MRMD","SG9999014021.USD","SG9999014005.SGD","BK4112","LU0314104364.USD","BK4588","NDAQ","SG9999014039.USD","BK4007","BK4585","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014013.SGD"],"gpt_icon":0},{"id":"2582870150","title":"Noble Financial Remains a Buy on MariMed (MRMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582870150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582870150?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:56","pubTimestamp":1762786589,"startTime":"0","endTime":"0","summary":"Noble Financial analyst Joe Gomes maintained a Buy rating on MariMed today and set a price target of $0.25. Gomes covers the Industrials sector, fo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/noble-financial-remains-a-buy-on-marimed-mrmd-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/noble-financial-remains-a-buy-on-marimed-mrmd-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBL","MRMD","BK4007"],"gpt_icon":0},{"id":"2581089437","title":"Press Release: MariMed Reports Third Quarter 2025 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2581089437","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581089437?lang=en_us&edition=fundamental","pubTime":"2025-11-06 07:48","pubTimestamp":1762386480,"startTime":"0","endTime":"0","summary":"NORWOOD, Mass., Nov. 05, 2025  -- MariMed Inc.   , a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the third quarter ended September 30, 2025.\"We delivered sequential growth in both wholesale and retail revenues for the third quarter, and reported a substantial increase in adjusted net income,\" said Mario Pinho, MariMed Chief Financial Officer. \"\"Wholesale expansion in Massachusetts and Illinois, the launch of adult-use sales in Delaware, and higher retail transactions across our network fueled topline growth. While new competition impacted our Metropolis, Illinois location, we improved profitability through disciplined cost management and operational efficiencies, without compromising product quality or the customer experience.\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","BK4585","BK4007","BK4588","BK4604","03160","TM","MRMD","BK4099"],"gpt_icon":0},{"id":"2581083416","title":"MariMed Q3 revenue misses analyst expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2581083416","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581083416?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:32","pubTimestamp":1762381951,"startTime":"0","endTime":"0","summary":"MariMed Q3 revenue misses analyst expectationsOverviewMariMed Q3 revenue misses analyst expectations, adjusted EBITDA also missed estimates Company reports sequential growth in wholesale and retail re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL1N3WH1PX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRMD","BK4007"],"gpt_icon":0},{"id":"2581088941","title":"Marimed Inc. reports third quarter revenue of $40.8 million and net loss of $2.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581088941","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581088941?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:05","pubTimestamp":1762380310,"startTime":"0","endTime":"0","summary":"Marimed Inc. reported third quarter 2025 revenue of $40.8 million, a slight increase from $40.6 million in the same period in 2024. GAAP gross margin was 40%, compared to 41% last year. The company recorded a GAAP net loss of $2.9 million, widening from a $1.0 million net loss in the prior year period. Non-GAAP gross margin was 41%, down from 43%, while Non-GAAP adjusted EBITDA was $5.1 million, up from $4.7 million. Key business developments included sequential growth in both wholesale and retail revenues, expansion of wholesale sales in Massachusetts and Illinois, the launch of adult-use sales in Delaware, and new distribution agreements for the company's brands in Maine, Pennsylvania, and New York.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDLTqVJJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MRMD"],"gpt_icon":0},{"id":"2581700219","title":"BRIEF-MariMed Q3 Adjusted EBITDA USD 5.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581700219","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581700219?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:00","pubTimestamp":1762380047,"startTime":"0","endTime":"0","summary":"BRIEF-MariMed Q3 Adjusted EBITDA USD 5.1 Million\n\n\nNov 05 (Reuters) - MariMed Q3 gross margin 40%.\n\nQ3 revenue USD 40.8 million\nQ3 net income USD -2.9 million\nQ3 adjusted gross margin 41%\nQ3 adjusted EBITDA margin 13%\nQ3 adjusted net income USD -1.5 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nPLXDB7119:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRMD","BK4007"],"gpt_icon":0},{"id":"2581007827","title":"MariMed Q3 Gross Margin 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581007827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581007827?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:00","pubTimestamp":1762380003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nPLXDB7119:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRMD","BK4007"],"gpt_icon":0},{"id":"2581007177","title":"MariMed Q3 Adjusted Gross Margin 41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581007177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581007177?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:00","pubTimestamp":1762380003,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nPLXDB7119:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRMD","BK4007"],"gpt_icon":0},{"id":"2579918080","title":"BRIEF-Marimed Announces Exit From Missouri Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2579918080","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579918080?lang=en_us&edition=fundamental","pubTime":"2025-10-29 05:49","pubTimestamp":1761688164,"startTime":"0","endTime":"0","summary":"BRIEF-Marimed Announces Exit From Missouri MarketOct 28 (Reuters) - Marimed Inc MRMD.PK:MARIMED INC - ANNOUNCES EXIT FROM MISSOURI MARKETSource text: ID:nGNX6lRryRFurther company coverage: MRMD.PK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W91P3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRMD","BK4007"],"gpt_icon":0},{"id":"2579972669","title":"MariMed Inc - Announces Exit From Missouri Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2579972669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579972669?lang=en_us&edition=fundamental","pubTime":"2025-10-29 05:00","pubTimestamp":1761685225,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W91P3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRMD","BK4007"],"gpt_icon":0},{"id":"2577067223","title":"Marimed to expand distribution to New York","url":"https://stock-news.laohu8.com/highlight/detail?id=2577067223","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577067223?lang=en_us&edition=fundamental","pubTime":"2025-10-23 19:40","pubTimestamp":1761219655,"startTime":"0","endTime":"0","summary":"MariMed (MRMD) announced a licensing agreement with Farm 2 Hand that will introduce the Company’s top-selling portfolio of products throughout New ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/marimed-to-expand-distribution-to-new-york-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/marimed-to-expand-distribution-to-new-york-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRMD","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}